ID   PLXB3_MOUSE             Reviewed;        1902 AA.
AC   Q9QY40; A2AFF9; Q80TH8;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   31-OCT-2012, sequence version 2.
DT   07-APR-2021, entry version 146.
DE   RecName: Full=Plexin-B3;
DE   AltName: Full=Plexin-6;
DE   Flags: Precursor;
GN   Name=Plxnb3; Synonyms=Kiaa1206, Plxn6;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Platzer M., Brenner V., Reichwald K., Wiehe T., Oksche A., Rosenthal A.;
RT   "Comparative sequence analysis of the mouse L1cam locus and the
RT   corresponding region of human Xq28.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 352-1902.
RC   TISSUE=Brain;
RX   PubMed=12693553; DOI=10.1093/dnares/10.1.35;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S.,
RA   Nakajima D., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: II.
RT   The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:35-48(2003).
RN   [4]
RP   SEQUENCE REVISION.
RA   Okazaki N., Kikuno R., Nagase T., Ohara O., Koga H.;
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15218527; DOI=10.1038/sj.embor.7400189;
RA   Artigiani S., Conrotto P., Fazzari P., Gilestro G.F., Barberis D.,
RA   Giordano S., Comoglio P.M., Tamagnone L.;
RT   "Plexin-B3 is a functional receptor for semaphorin 5A.";
RL   EMBO Rep. 5:710-714(2004).
RN   [6]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=15147296; DOI=10.1111/j.0953-816x.2004.03401.x;
RA   Worzfeld T., Puschel A.W., Offermanns S., Kuner R.;
RT   "Plexin-B family members demonstrate non-redundant expression patterns in
RT   the developing mouse nervous system: an anatomical basis for morphogenetic
RT   effects of Sema4D during development.";
RL   Eur. J. Neurosci. 19:2622-2632(2004).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=16122393; DOI=10.1186/1471-2202-6-53;
RA   Hartwig C., Veske A., Krejcova S., Rosenberger G., Finckh U.;
RT   "Plexin B3 promotes neurite outgrowth, interacts homophilically, and
RT   interacts with Rin.";
RL   BMC Neurosci. 6:53-53(2005).
RN   [8]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=19699796; DOI=10.1016/j.mcn.2009.08.008;
RA   Worzfeld T., Rauch P., Karram K., Trotter J., Kuner R., Offermanns S.;
RT   "Mice lacking Plexin-B3 display normal CNS morphology and behaviour.";
RL   Mol. Cell. Neurosci. 42:372-381(2009).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH ARHGDIA AND RAC1.
RX   PubMed=20696765; DOI=10.1074/jbc.m110.120451;
RA   Li X., Lee A.Y.;
RT   "Semaphorin 5A and plexin-B3 inhibit human glioma cell motility through
RT   RhoGDIalpha-mediated inactivation of Rac1 GTPase.";
RL   J. Biol. Chem. 285:32436-32445(2010).
RN   [10]
RP   INTERACTION WITH FSCN1.
RX   PubMed=21706053; DOI=10.1038/onc.2011.256;
RA   Li X., Law J.W., Lee A.Y.;
RT   "Semaphorin 5A and plexin-B3 regulate human glioma cell motility and
RT   morphology through Rac1 and the actin cytoskeleton.";
RL   Oncogene 31:595-610(2012).
CC   -!- FUNCTION: Receptor for SEMA5A that plays a role in axon guidance,
CC       invasive growth and cell migration. Stimulates neurite outgrowth and
CC       mediates Ca(2+)/Mg(2+)-dependent cell aggregation. In glioma cells,
CC       SEMA5A stimulation of PLXNB3 results in the disassembly of F-actin
CC       stress fibers, disruption of focal adhesions and cellular collapse as
CC       well as inhibition of cell migration and invasion through ARHGDIA-
CC       mediated inactivation of RAC1 (By similarity). Seem to be non-essential
CC       for normal development and function of the central nervous system.
CC       {ECO:0000250, ECO:0000269|PubMed:15218527,
CC       ECO:0000269|PubMed:20696765}.
CC   -!- SUBUNIT: Binds MET and MST1R. Interacts with RIT2/RIN. May form
CC       homodimers (via Sema domain) (By similarity). Interacts (via
CC       cytoplasmic domain) with FSCN1, ARHGDIA and RAC1. {ECO:0000250,
CC       ECO:0000269|PubMed:20696765, ECO:0000269|PubMed:21706053}.
CC   -!- INTERACTION:
CC       Q9QY40; Q61553: Fscn1; NbExp=3; IntAct=EBI-6271317, EBI-2308857;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}. Note=Colocalizes with RIT2/RIN at the
CC       plasma membrane. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain (at protein level). In
CC       cerebellum, strongest expression detected in Purkinje and granular
CC       cells. Detected at very low levels in several fetal tissues, including
CC       dorsal root ganglia (DRG), heart, lung, optic bulb, brain and liver.
CC       {ECO:0000269|PubMed:15218527, ECO:0000269|PubMed:16122393}.
CC   -!- DEVELOPMENTAL STAGE: In brain, detected first perinatally, with
CC       expression reaching maximal levels at postnatal day 9 (P9). In the
CC       developing nervous system, barely detectable until birth, and
CC       postnatally expressed in white matter tracks including the corpus
CC       callosum, external capsule, fimbria hippocampi and corticospinal
CC       tracts. In spinal cord, not detected until birth, and postnatally
CC       expressed in spinal white matter. In cerebellum, expressed only in
CC       cerebellar white matter cells, with expression detected first shortly
CC       after birth in the cerebellar peduncle and increasing progressively in
CC       the white matter tracts of the cerebellar lobes until P10.
CC       {ECO:0000269|PubMed:15147296}.
CC   -!- DISRUPTION PHENOTYPE: Mutant mice are viable and fertile and display no
CC       obvious morphological abnormalities in the brain or spinal cord.
CC       {ECO:0000269|PubMed:19699796}.
CC   -!- SIMILARITY: Belongs to the plexin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC65749.2; Type=Erroneous gene model prediction; Note=Contains intronic sequences.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF133093; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL672094; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK122467; BAC65749.2; ALT_SEQ; Transcribed_RNA.
DR   CCDS; CCDS41013.1; -.
DR   RefSeq; NP_062533.2; NM_019587.2.
DR   RefSeq; XP_006527842.1; XM_006527779.1.
DR   RefSeq; XP_006527843.1; XM_006527780.2.
DR   SMR; Q9QY40; -.
DR   BioGRID; 228284; 6.
DR   IntAct; Q9QY40; 2.
DR   MINT; Q9QY40; -.
DR   STRING; 10090.ENSMUSP00000002079; -.
DR   GlyConnect; 2595; 1 N-Linked glycan (1 site).
DR   GlyGen; Q9QY40; 10 sites.
DR   iPTMnet; Q9QY40; -.
DR   PhosphoSitePlus; Q9QY40; -.
DR   jPOST; Q9QY40; -.
DR   PaxDb; Q9QY40; -.
DR   PeptideAtlas; Q9QY40; -.
DR   PRIDE; Q9QY40; -.
DR   ProteomicsDB; 289844; -.
DR   Antibodypedia; 369; 97 antibodies.
DR   Ensembl; ENSMUST00000002079; ENSMUSP00000002079; ENSMUSG00000031385.
DR   GeneID; 140571; -.
DR   KEGG; mmu:140571; -.
DR   UCSC; uc009tmn.2; mouse.
DR   CTD; 5365; -.
DR   MGI; MGI:2154240; Plxnb3.
DR   eggNOG; KOG3610; Eukaryota.
DR   GeneTree; ENSGT01020000230394; -.
DR   HOGENOM; CLU_001436_1_1_1; -.
DR   InParanoid; Q9QY40; -.
DR   OMA; CQAQQFH; -.
DR   OrthoDB; 90434at2759; -.
DR   TreeFam; TF312962; -.
DR   Reactome; R-MMU-416700; Other semaphorin interactions.
DR   BioGRID-ORCS; 140571; 0 hits in 52 CRISPR screens.
DR   ChiTaRS; Plxnb3; mouse.
DR   PRO; PR:Q9QY40; -.
DR   Proteomes; UP000000589; Chromosome X.
DR   RNAct; Q9QY40; protein.
DR   Bgee; ENSMUSG00000031385; Expressed in mesenteric lymph node and 211 other tissues.
DR   Genevisible; Q9QY40; MM.
DR   GO; GO:0009986; C:cell surface; ISO:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0002116; C:semaphorin receptor complex; IBA:GO_Central.
DR   GO; GO:0098632; F:cell-cell adhesion mediator activity; ISO:MGI.
DR   GO; GO:0019904; F:protein domain specific binding; ISS:UniProtKB.
DR   GO; GO:0051022; F:Rho GDP-dissociation inhibitor binding; IPI:UniProtKB.
DR   GO; GO:0017154; F:semaphorin receptor activity; ISS:UniProtKB.
DR   GO; GO:0060326; P:cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; ISO:MGI.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0034260; P:negative regulation of GTPase activity; ISS:UniProtKB.
DR   GO; GO:0010593; P:negative regulation of lamellipodium assembly; ISS:UniProtKB.
DR   GO; GO:0050918; P:positive chemotaxis; ISS:UniProtKB.
DR   GO; GO:0050772; P:positive regulation of axonogenesis; IBA:GO_Central.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; ISO:MGI.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISO:MGI.
DR   GO; GO:0030334; P:regulation of cell migration; IBA:GO_Central.
DR   GO; GO:0008360; P:regulation of cell shape; IBA:GO_Central.
DR   GO; GO:0043087; P:regulation of GTPase activity; IBA:GO_Central.
DR   GO; GO:0071526; P:semaphorin-plexin signaling pathway; ISS:UniProtKB.
DR   GO; GO:1902287; P:semaphorin-plexin signaling pathway involved in axon guidance; IBA:GO_Central.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 2.60.40.10; -; 4.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR002909; IPT_dom.
DR   InterPro; IPR031148; Plexin.
DR   InterPro; IPR013548; Plexin_cytoplasmic_RasGAP_dom.
DR   InterPro; IPR002165; Plexin_repeat.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR001627; Semap_dom.
DR   InterPro; IPR036352; Semap_dom_sf.
DR   InterPro; IPR041019; TIG1_plexin.
DR   InterPro; IPR041362; TIG2_plexin.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   PANTHER; PTHR22625; PTHR22625; 1.
DR   Pfam; PF08337; Plexin_cytopl; 1.
DR   Pfam; PF01437; PSI; 1.
DR   Pfam; PF01403; Sema; 1.
DR   Pfam; PF01833; TIG; 3.
DR   Pfam; PF18020; TIG_2; 1.
DR   Pfam; PF17960; TIG_plexin; 1.
DR   SMART; SM00429; IPT; 3.
DR   SMART; SM00423; PSI; 3.
DR   SMART; SM00630; Sema; 1.
DR   SUPFAM; SSF101912; SSF101912; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF81296; SSF81296; 3.
DR   PROSITE; PS51004; SEMA; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; Glycoprotein; Membrane; Neurogenesis;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..36
FT                   /evidence="ECO:0000255"
FT   CHAIN           37..1902
FT                   /note="Plexin-B3"
FT                   /id="PRO_0000024675"
FT   TOPO_DOM        37..1245
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1246..1266
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1267..1902
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          37..461
FT                   /note="Sema"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT   DOMAIN          463..515
FT                   /note="PSI 1"
FT   DOMAIN          609..671
FT                   /note="PSI 2"
FT   DOMAIN          776..822
FT                   /note="PSI 3"
FT   DOMAIN          823..914
FT                   /note="IPT/TIG 1"
FT   DOMAIN          915..1001
FT                   /note="IPT/TIG 2"
FT   DOMAIN          1003..1134
FT                   /note="IPT/TIG 3"
FT   DOMAIN          1154..1221
FT                   /note="IPT/TIG 4"
FT   CARBOHYD        41
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        221
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        416
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        469
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        791
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        889
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        910
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        946
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1090
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1207
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        88..97
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT   DISULFID        122..130
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT   DISULFID        257..360
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT   DISULFID        273..305
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT   DISULFID        323..347
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT   DISULFID        464..481
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT   DISULFID        470..514
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT   DISULFID        473..490
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT   DISULFID        484..496
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT   DISULFID        551..569
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT   CONFLICT        352
FT                   /note="P -> V (in Ref. 4; BAC65749)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1566..1601
FT                   /note="Missing (in Ref. 4; BAC65749)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1902 AA;  208366 MW;  25F8DE49B6C98071 CRC64;
     MLTDFLQAPV MAPWSPFSLH LLLLFLPLLP LTRVHRFSVP NTSFNHLVLA PDQGKLYVGA
     VNHLFQLSPE LKMESVAVTG PVIDSPDCVP FRDLAECPQA QLTDNANQLL LVSSRTQELV
     ACGQVKQGVC EKRRLGDVTQ VLYQAEDPGD GQFVAANTLG VTTVGLVVPL PGRDLLLVAR
     GLAGKLSAGV PPLTVRQLAG PQPFSSEGLG RLVVGDFSDY NNSYVGAFSD AHSAYFVFRR
     RGARAQTEYR SYVARVCLRD VNLYSYVEMP LTCHGQGLIQ AAFLTPDTLL GAFSAGTSQA
     QAALCAFPLA DLDRSMEQAR RLCYTTGGQG PSGMEEATVE YGVTSRCVTL PPDSPESYPC
     GDEHTPSPIA GRQPLEAQPL LQLGQSISAV AALQTDGHTI AFLGDTQGQL HKVFLNSSHG
     QVYHSQQVGP PGSAISPDLL VDSNGDHLYV LTAQQVDRIL VAACPQFPNC TTCLQARDPL
     CGWCILQGRC TRRGECGRAA QPNHWLWSYE DNHCPYIQSL LPAQHPRQEQ GQIILSVPRL
     PTLAMDEYFH CAFGGYNSLA QVEEPHVVCT TPPQDQMPPN PPGSDHVTLP LALMFEDVVL
     TATTFSFYDC SAVQALEVAA PCRACVSSLW RCHWCPQSSH CIYGEHCPEG EKAVYSAQEV
     DILVRGPEAC PQVEGLASPQ LVPVGWESHV TLHIQNLHYF QGLPALYHCW LELPGKLQKL
     PASLEETSRD SGLIHCQAQQ FYPSMSQWEL PVPIYVTRGE IQRLDNAGDL HVTLYDCAMG
     HPDCSHCQAA NGSLSCLWCG DGQPACRYGP LCPPGAVEQL CPIPSIDVIE PLTGPPEGGL
     AITILGSNLG QAFNDVRNAV TVAGQPCNPD PSLYRISARI VCVTSPAPNG TAGPVQVAIK
     SRPPGISTQN FTYQDPVLLS LNPQWGPQAG GTQLTIHGQY LQTGGNISVF VGDQPCPIQE
     PVCPEAIICH TMPQTEPGEA VVLIVFGHVE RKLLTTPFRY TANPQLVEAE PSVSFRGGGR
     VIRVRGTGLD VVWQPLLSVW LEDEPKVKAL GVQAQDANPR RSCGAPAADP QACIHLESGL
     LQCSTLCSVN SSSLLLCHSP AVPDGALPKR VFFALDNMQV DFASASGGQG FLYQPNPRLA
     PLSHEGITHP YHLKPGHVLD VEGEGLNLGI SKEEVQVHIG DGECLVKTLT LTHLYCEPPP
     QAPQPTNGSG TLPQFVVQMG NLRLALGPVQ YEAESMMSTF PVEAQLGLGM GAAVLIAAVL
     LLTLMYRHKS KKALRDYQKV LVQLENLETG VGDQCRKEFT DLMTEMTDLT SDLEASGIPF
     LDYRTYAERA FFPGHVGCPL QPGLEGLGEE GRSVTVRQGL TQLSNLLNSK LFLLTLIHTL
     EEQPSFSQRD RCHVASLLSL ALHSKLEYLT DIMRTLLGDL AAHYVHKNPK LMLRRTETMV
     EKLLTNWLSI CLYTFLKEVA GEPLYMLFRA IKYQVDKGPV DAVTGKAKRT LNDSHLLRED
     VEFQPLTLMA LVGPEADRAA GNSGVHRVPA RVLDTDTITQ VKEKVLDQIY KGTPFSQRPS
     VHSLDLEWRS GLAGHLTLSD EDLTSVTQNH WKRLNTLQHY KVPDGATVVL IPQVHNGGTV
     SQSLGQTGCP SGENTPMLED GEEGGVRLWH LVKATEEAEG AKVRRSSLRD RERERSRAKA
     IPEIYLTRLL SMKGTLQKFV DDTFQAILSM NRPVPIAVKY LFDFLDELAE KHGIEDPETL
     HIWKTNSLLL RFWVNVLKNP QLIFDVQVSD NEDAILAVIA QTFIDSCMVS EHKVGRDSPV
     NKLLYAREIP RYKQMVEKYY ADIRQSSPAS YQEMNSALAE LSGNYSSAPH CLEALRELYN
     HIHRYYDQII SALEEDPVAQ KMQLACRLQQ VAALVEYKVT DL
//
